Full Length Research Paper
References
Bennett DE, Bertagnolio S, Sutherland D, Gilks CF (2008). The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir. Ther. 13:1-13. |
|
Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez W (2007). HIV viral Load Monitoring in Resource-Limited Regions: Optional or Necessary? Clin. Infect. Dis. 44(1):128-134. |
|
Government of Nepal, Ministry of Health and Population (2014). National Centre for AIDS & STD Control (NCASC),National Consolidated Guideline for Treating and Preventing HIV in Nepal, 2014 Available at: |
|
Liégeois F, Vella C, Eymard-Duvernay S, Sica J, Makosso L, Mouinga-Ondémé A, Mongo AD, Boué V, Butel C, Peeters M, Gonzalez JP, Delaporte E, Rouet F (2012). Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon. J. Int. AIDS Soc. 15(2):17985. |
|
Ministry of Health Government of Lesotho (2014). National guidelines on the use of antiretroviral therapy for HIV prevention and treatment (Fourth Edition) Ministry of Health Government of Lesotho June 2014. Available at: |
|
Mylonakis E, Paliou M, Rich JD (2001). Plasma Viral Load Testing in the Management of HIV Infection. Am. Fam. Phys. 63(3):483-491. |
|
National Centre for AIDS and STD Control (NCASC) (2009). National Anti-retroviral Therapy Guidelines. Available at: |
|
Ojha CR, Shakya G, Dumre SP (2016). Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal. BioMed Res. Int. 2016:6817325. |
|
Policy brief (2015). Viral load testing for HIV treatment monitoring in Uganda. Available at: |
|
Stevens WS, Marshall TM (2010). Challenges in Implementing HIV Viral Load Testing in South Africa. J. Infect. Dis. 201(S1):S78-S84. |
|
UN:UNAIDS (2014). 90–90–90 - An ambitious treatment target to help end the AIDS epidemic. Available at: |
|
World Health Organization (WHO) (2013a). Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization. P 269. |
|
World Health Organization (WHO) (2013b). WHO definitions of clinical, immunological and virological failure for the decision to switch ART regimens. Available at: |
|
World Health Organization (WHO) (2014). Technical and operational considerations for implementing HIV viral load testing: interim technical update, 2014. Available at: |
|
Zhou Y, Lu J, Wang J, Yan H, Li J, Xu X, Zhang Z, Qiu T, Ding P, Fu G, Huan X (2016). Prevalence of HIV antiretroviral drug resistance and its impacts on HIV-1 virological failures in Jiangsu, China: A cross-sectional study. BioMed Res. Int. 2016:2016. |
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0